BluMaiden utilizes artificial intelligence (AI) to revolutionize small-molecule drug discovery by streamlining the process of designing new drugs. By harnessing AI algorithms, BluMaiden efficiently analyzes massive amounts of data to predict how molecules will interact with biological targets, enabling the identification of potential drug candidates more quickly and accurately. This innovative approach has the potential to significantly accelerate the development of new medications and improve treatment options for various diseases.
Source link
China cracks down on Calvin Klein, Tommy Hilfiger parent companies | News
China's MOFCOM added PVH and Illumina to its 'unreliable entity' list for violating market principles and discriminating against Chinese companies, amid escalating US-China trade tensions. PVH faces scrutiny for alleged improper conduct in Xinjiang, impacting its presence in China, while Illumina's inclusion reflects broader geopolitical tensions. The move comes as part of China's response to US sanctions, signaling increased scrutiny of US corporations operating in China. Full Article
Read more